home / stock / xrtxf / xrtxf quote
Last: | $0.4486 |
---|---|
Change Percent: | 0.72% |
Open: | $0.4302 |
Close: | $0.4486 |
High: | $0.4486 |
Low: | $0.4302 |
Volume: | 4,904 |
Last Trade Date Time: | 09/22/2021 10:46:14 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.4486 | $0.4302 | $0.4486 | $0.4486 | $0.4302 | 4,904 | 09-22-2021 |
$0.4454 | $0.4381 | $0.4454 | $0.4618 | $0.43 | 44,586 | 09-21-2021 |
$0.4094 | $0.4337 | $0.4094 | $0.4373 | $0.3884 | 64,290 | 09-20-2021 |
$0.4635 | $0.4811 | $0.4635 | $0.4811 | $0.4407 | 27,410 | 09-17-2021 |
$0.4552 | $0.4741 | $0.4552 | $0.4741 | $0.4496 | 41,255 | 09-16-2021 |
$0.5206 | $0.5738 | $0.5206 | $0.5738 | $0.5202 | 107,554 | 09-10-2021 |
$0.5563 | $0.5549 | $0.5563 | $0.5911 | $0.5298 | 82,705 | 09-09-2021 |
$0.558 | $0.6972 | $0.558 | $0.6972 | $0.5271 | 325,986 | 09-08-2021 |
$0.61 | $0.56875 | $0.61 | $0.6114 | $0.5164 | 376,526 | 09-07-2021 |
$0.4943 | $0.4332 | $0.4943 | $0.5222 | $0.4065 | 681,508 | 09-06-2021 |
$0.4943 | $0.4332 | $0.4943 | $0.5222 | $0.4065 | 681,508 | 09-03-2021 |
$0.4165 | $0.4126 | $0.4165 | $0.4458 | $0.395 | 666,265 | 09-02-2021 |
$0.4 | $0.4035 | $0.4 | $0.45 | $0.3786 | 185,105 | 09-01-2021 |
$0.3567 | $0.329 | $0.3567 | $0.3686 | $0.329 | 37,630 | 08-31-2021 |
$0.32 | $0.3138 | $0.32 | $0.3395 | $0.3138 | 61,372 | 08-30-2021 |
$0.2931 | $0.3085 | $0.2931 | $0.3085 | $0.2853 | 371,884 | 08-27-2021 |
$0.3075 | $0.342 | $0.3075 | $0.342 | $0.3075 | 42,339 | 08-26-2021 |
$0.3412 | $0.3126 | $0.3412 | $0.35 | $0.3126 | 10,305 | 08-25-2021 |
$0.327 | $0.3446 | $0.327 | $0.3456 | $0.3018 | 84,232 | 08-24-2021 |
$0.3236 | $0.3341 | $0.3236 | $0.3341 | $0.3221 | 68,665 | 08-23-2021 |
News, Short Squeeze, Breakout and More Instantly...
XORTX Therapeutics Inc Company Name:
XRTXF Stock Symbol:
OTCMKTS Market:
XORTX Therapeutics Inc Website:
CALGARY, Alberta, April 22, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive...
CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ) , a biopharmaceutical company focused on developing innovative therapies to treat autosomal dominant polycystic kidney...